In animals treated with anti-G-CSF, the circulation of tumor-associated myeloid cells was significantly reduced compared to that of untreated animals, demonstrating the important role of G-CSF in tumor refractoriness after bevacizumab treatment28. Here, CSF3 is linked to neoplasm.